|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
1994-5-12
|
|
pubmed:abstractText |
To determine the response rate to 2-chlorodeoxyadenosine (2-CdA; cladribine) in patients with advanced indolent non-Hodgkin's lymphoma (NHL) who fail to respond to or progress after a response to standard chemotherapy drugs.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
12
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
788-92
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:7908690-Adolescent,
pubmed-meshheading:7908690-Adult,
pubmed-meshheading:7908690-Aged,
pubmed-meshheading:7908690-Cladribine,
pubmed-meshheading:7908690-Female,
pubmed-meshheading:7908690-Humans,
pubmed-meshheading:7908690-Lymphoma, Non-Hodgkin,
pubmed-meshheading:7908690-Male,
pubmed-meshheading:7908690-Middle Aged,
pubmed-meshheading:7908690-Salvage Therapy,
pubmed-meshheading:7908690-Treatment Outcome
|
|
pubmed:year |
1994
|
|
pubmed:articleTitle |
2-Chlorodeoxyadenosine is an active salvage therapy in advanced indolent non-Hodgkin's lymphoma.
|
|
pubmed:affiliation |
Long Island Jewish Medical Center, Albert Einstein College of Medicine, New Hyde Park, NY 11042.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
